[Treatment of the endometrial adenomatosis with tamoxifen in patients of reproductive age].
Smetnik
V P
VP
Chernukha
G E
GE
Kushlinskiĭ
N E
NE
D000236:Adenoma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D000328:Adult; D004714:Endometrial Hyperplasia / Q000097:blood / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D016889:Endometrial Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D004717:Endometrium / Q000187:drug effects / Q000473:pathology; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D011247:Pregnancy; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D004967:Estrogens; D013629:Tamoxifen
Lechenie adenomatoza éndometriia tamoksifenom u bol'nykh reproduktivnogo vozrasta.